At Rosefinch, our aim is to identify, develop and commercialize new therapeutic products that save lives by preventing or treating serious medical conditions.
We are committed to significantly investing in future R&D portfolio and capabilities in the areas of Cardiology, Psychiatry, Inflammation, Immunology, Oncology and allied specialties.
Rosefinch Pharmaceutique dedicates itself to provide scientists with powerful and innovative tools to screen potential new drugs and identify promising targets for treating medical conditions.
In pursuit of drugs with new mechanisms of action and new delivery systems to treat medical conditions, our research seeks to enhance the effectiveness and safety of drug therapy.
Our researchers have expertise in Pharmacology, Molecular biology, Combinatorial chemistry, Insilico drug designing and other scientific disciplines.